CYTOGENETIC CLONALITY IN MYELODYSPLASTIC SYNDROMES (MDS) STUDIED WITH FLUORESCENCE INSITU HYBRIDIZATION (FISH) - LINEAGE, RESPONSE TO GROWTH-FACTOR (GF) THERAPY AND CLONE EXPANSION

被引:0
|
作者
ANASTASI, J [1 ]
FENG, J [1 ]
LEBEAU, MM [1 ]
LARSON, RA [1 ]
ROWLEY, JD [1 ]
VARDIMAN, JW [1 ]
机构
[1] UNIV CHICAGO,CHICAGO,IL 60637
关键词
D O I
暂无
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
引用
收藏
页码:A84 / A84
页数:1
相关论文
共 4 条
  • [1] CYTOGENETIC CLONALITY IN MYELODYSPLASTIC SYNDROMES STUDIED WITH FLUORESCENCE INSITU HYBRIDIZATION - LINEAGE, RESPONSE TO GROWTH-FACTOR THERAPY, AND CLONE EXPANSION
    ANASTASI, J
    FENG, JJ
    LEBEAU, MM
    LARSON, RA
    ROWLEY, JD
    VARDIMAN, JW
    BLOOD, 1993, 81 (06) : 1580 - 1585
  • [2] Conventional cytogenetic (CC), fluorescence in situ hybridization (FISH) and comparative genomic hybridization (CGH) analysis in patients with myelodysplastic syndromes (MDS)
    Skonieczka, Olga Haus
    Duszenko, Ewa
    Mucha, Barbara
    Babicz, Mariusz
    Wyrowinska, Elzbieta
    Swistek, Wojciech
    CHROMOSOME RESEARCH, 2007, 15 : 203 - 204
  • [3] Update of cytogenetic risk factors in MDS (Part II): a strategy to incorporate fluorescence in situ hybridization (FISH) and "FISH on a Chip" (aCGH) results in future clinical trials for the myelodysplastic syndromes (MDS)
    Slovak, M. L.
    Dewald, G.
    LEUKEMIA RESEARCH, 2009, 33 : S10 - S10
  • [4] Artificial intelligence (AI)-powered assessment of complete and intense human epidermal growth factor receptor 2 (HER2)-positive tumor cell proportion in breast cancer: Predicting fluorescence in situ hybridization (FISH) positivity and response to HER2-targeted therapy
    Jung, M.
    Kim, S-W.
    Song, S. G.
    Baek, S. K.
    Cho, S. I.
    Shin, S.
    Kim, S.
    Song, H.
    Park, S.
    Pereira, S.
    Yoo, D.
    ANNALS OF ONCOLOGY, 2023, 34 : S329 - S329